SCHEMBL457902

SCHEMBL457902

Cc1cc(-c2cnc3c(NCCC(F)(F)F)cc(Oc4ccc(Cl)cc4)nn23)ccc1C(=O)O

nearest known ligand 0.60

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TTK P33981 20/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15555114 0.92 TTK (0.62) TTK
SCHEMBL456480 0.91 TTK (0.61) TTK
SCHEMBL455284 0.90 TTK (0.75) TTK
SCHEMBL457267 0.88 TTK (0.60) TTK
SCHEMBL10279499 0.87 TTK (0.61) TTK
SCHEMBL469939 0.85 TTK (0.57) TTK
SCHEMBL10279537 0.85 TTK (0.60) TTK
SCHEMBL457420 0.84 TTK (0.66) TTK
SCHEMBL17416378 0.84 TTK (0.64) TTK
SCHEMBL457429 0.83 TTK (0.77) TTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9255100-B2 Substituted imidazopyridazines BAYER INTELLECTUAL PROPERTY GMBH (DE) 2016-02-09 US disclosed
EP-2614063-B1 SUBSTITUTED IMIDAZOPYRIDAZINES BAYER IP GMBH (DE) 2016-01-13 EP disclosed
EP-2614063-A1 SUBSTITUTED IMIDAZOPYRIDAZINES Bayer Intellectual Property GmbH (DE) 2013-07-17 EP disclosed
WO-2012032031-A1 SUBSTITUTED IMIDAZOPYRIDAZINES BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2012-03-15 WO disclosed
WO-2012032031-A1 SUBSTITUTED IMIDAZOPYRIDAZINES BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2012-03-15 WO disclosed